Ticker: KALV

Company: Carbylan Therapeutics, Inc.

Person: Benjamin L Palleiko, director, officer

Transaction date: Nov. 17, 2025

Reporting date: Nov. 19, 2025

Average share price: -13.202327562270314

Sold 4898.0 shares for 64665.0